CXCR4 and acute lymphoblastic leukemia: In a different study, pharmacological CXCR4 antagonists inhibited bone marrow colonization by T-ALLs and reduced the neuropathologies associated with CNS infiltration [196], suggesting that CXCR4 may be a potential therapeutic target to eradicate CNS affectation in T-ALL patients.